LOS ANGELES, CA / ACCESS Newswire / March 18, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of ...

Fermentation has evolved into precision fermentation, utilizing biotechnology to engineer microorganisms that produce ...

Stämm launched the High-Throughput Bioprocessor (HTB), an automated, single-use biomanufacturing platform for adherent and suspension cells. The HTB is engineered to eliminate the infrastructure ...

There is a new, U.S.-based, environmentally friendly method for mining rare-earth elements used in consumer electronics, ...

The approach harnesses the power of bacteria to transform post-consumer plastic into L-DOPA, a frontline medication for the ...

A research team affiliated with UNIST has engineered a microbial strain capable of rapidly growing in high concentrations of ...

Scientists at University of Edinburgh engineered bacteria to convert plastic bottles into L-DOPA, a Parkinson's medication, ...

Plastic waste is becoming an increasing problem, with 50 million tonnes of single-use plastic being produced each year. Plastics are used in the packaging of food and drinks.

A drug to treat Parkinson's disease can be made from waste plastic bottles using a pioneering method, a study shows. The approach harnesses the power of bacteria to transform post-consumer plastic ...

Scientists make Parkinson’s drug from used plastic bottles - Researchers said the breakthrough could lead to a ‘bio-upcycling industry’ that uses waste materials to make things like flavourings and ...

The pilot run achieved approximately 99% reaction conversion, 90% isolated yield, and 535 grams of NCT at 99.6% pharma-grade purity. eXoZymes Inc. (NASDAQ:EXOZ) What makes this initial NCT pilot run ...

A closer look at how robotics is reshaping pharmaceutical manufacturing, from improving quality and compliance to enabling more scalable production, and where the technology is headed next.